
NRSN Market Capitalization Overview
Market Cap: $57.10M as of Jun 13, 2025
$57.10M
Past Month+$26.87M (88.89%)
As of Jun 13, 2025, NRSN has a market capitalization of $57.10M. Over the past 30 days, its market cap has increased by 62.84%, while in the last 12 months, it has increased by 129.74%.
Market capitalization represents the total value of NeuroSense Therapeutics Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NRSN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NRSN helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of NeuroSense Therapeutics Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
NRSN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of NRSN helps investors assess the company's size and compare it with competitors for better investment decisions.
NRSN Market Cap & Key Trends
See NeuroSense Therapeutics Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in NRSN
Order type
Buy in
Order amount
Est. shares
0 shares
NRSN Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $40.55M | +62.84% |
May 1, 2025 | $24.90M | +17.93% |
Apr 1, 2025 | $21.12M | -13.45% |
Mar 3, 2025 | $24.40M | -0.19% |
Feb 3, 2025 | $24.44M | +2.61% |
Jan 2, 2025 | $23.82M | +2.68% |
NRSN End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $57.10M | +129.74% |
2024 | $24.86M | +132.38% |
2023 | $10.70M | -24.91% |
2022 | $14.25M | -46.24% |
2021 | $26.50M | — |
FAQs About NeuroSense Therapeutics Ltd (NRSN) Market Cap
As of Jun 13, 2025, the market capitalization of NRSN is $57.10M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, NeuroSense Therapeutics Ltd’s market capitalization has increased by 88.89%, changing from $30.23M to $57.10M as of Jun 13, 2025.
In the last 3 months, NeuroSense Therapeutics Ltd’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, NeuroSense Therapeutics Ltd’s market capitalization increased from $10.70M in January to $24.86M in December, reflecting a 132.38% change.
In the past five years, NRSN has had a compound annual growth rate (CAGR) of -1.58% in market capitalization. This means its market cap has shrunk at an average rate of -1.58% per year.